Ramsay Healthcare swings to $160.7m HY profit on improved admissions
The news: Ramsay Healthcare swung to a 253.2% increase in half-year net profit after tax to $160.7 million, driven by performance improvements in the Australian business, after reporting a net loss of $104.9 million the prior corresponding period.
The numbers: This exceeded analysts’ forecasts of $152 million, according to Visible Alpha data.
Underlying earnings before interest and tax saw a 7.3% increase to $536.7 million, while underlying net profit in the Australian division rose 7.1% to $330.9 million.
The company declared a fully franked interim dividend of 42.5 cents per share.
The context: CEO Natalie Davis attributed the solid earnings result to the growth across therapeutic areas in the Australian healthcare segment, supported by higher patient admissions, and an increase in teams and doctors during the period.
However, she said the UK hospital business was impacted by NHS budgetary constraints, while the mental health facility Elysium faced weaker demand from local authorities.
The group forecast FY26 net financing expenses of between $590 million and $610 million, and lowered capital expenditure guidance to a range of $755 million and $795 million.
The source: ASX